Pimecrolimus 1% cream is effective in the treatment of psoriasis in an infant

European Journal of Dermatology

Volumn 19, Issue 2, 2009, Pages 168-169

  Canpolat, Filiz ^a   Cemil, Bengü Çevirgen ^a   Tatlican, Semih ^a   Eskioglu, Fatma ^a   Oktay, Murat ^a   Alper, Murat ^a  

^a DISKAPI YILDIRIM BEYAZIT TRAINING AND RESEARCH HOSPITAL   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

PIMECROLIMUS; SALICYLIC ACID; STEROID; DERMATOLOGICAL AGENT; DRUG DERIVATIVE; TACROLIMUS;

CASE REPORT; DRUG EFFICACY; DRUG TREATMENT FAILURE; DRUG WITHDRAWAL; FEMALE; HUMAN; HYPOPIGMENTATION; INFANT; LETTER; PSORIASIS; SKIN EXAMINATION; TREATMENT DURATION; UNSPECIFIED SIDE EFFECT;

DERMATOLOGIC AGENTS; FEMALE; HUMANS; INFANT; PSORIASIS; TACROLIMUS;

EID: 65449180383     PISSN: 11671122     EISSN: 19524013     Source Type: Journal    
DOI: 10.1684/ejd.2008.0583     Document Type: Letter

References (6)

1. Gisondi P, Ellis CN, Girolomoni G. Pimecrolimus in dermatology: atopic dermatitis and beyond. Int J Clin Pract2005; 59: 969-974.
2. Kreuter A, Sommer A, Hyun J, et al. 1% Pimecrolimus, 0.005% Calcipotriol, and 0,1% Betamethasone in the Treatment of lntertrigi-nous Psoriasis. Arch Dermatol 2006; 142: 1138-1143.
3. Jacobi A, Braeutigam M, Mahler V, Schultz E, Hertl M. Pimecrolimus 1% cream in the treatment of facial psoriasis: a 16-week open-label study. Dermatology 2008; 216: 133-136
4. Mansouri P, Farshi S. Pimecrolimus 1 percent cream in the treatment of psoriasis in a child. Dermatol Online J 2006; 12: 7.
5. Queille-Roussel C, Paul C, Duteil L, et al. The new topical ascomycin derivative SDZ ASM 981 does not induce skin atropy when applied to normal skin for 4 weeks: a randomized, double-blind controlled study. Br J Dermatol 2001; 144: 507-513.
6. Billich A, Aschauer H, Aszodi A, Stuetz A. Percutaneous absorption of drugs used in atopic eczema: Pimecrolimus permeates less through skin than CS and tacrolimus. Int J Pharmacol 2004; 269: 29-35.